GLPBio

MDR multidrug resistance

MDR (multidrug resistance) is a property that first identified in tumor cell, hat the resistance of tumor cell is to a variety of chemotherapy agent due to active efflux via transporter proteins.

Products Related to MDR multidrug resistance(44)

  • GC46809 structure
    GC46809Afatinib-d6
    CAS: 1313874-96-2
    Purity: >99.00%

    An internal standard for the quantification of afatinib

  • GC48119 structure
    GC48119Suprafenacine
    CAS: 1477482-50-0
    Purity: >98.00%

    An inhibitor of tubulin polymerization with anticancer activity

  • GC48219 structure
    GC48219Ulipristal Acetate-d6
    CAS: 1621894-64-1
    Purity: >99.00%

    An internal standard for the quantification of ulipristal acetate

  • GC48479 structure
    GC48479Migrastatin
    CAS: 314245-65-3
    Purity: >90.00%

    A fungal metabolite with antimuscarinic and anticancer activities

  • GC49106 structure
    GC49106Gentisein
    CAS: 529-49-7
    Purity: >95.00%

    A xanthone with diverse biological activities

  • GC49251 structure
    GC49251Oxaliplatin-d10
    CAS: 1132819-16-9
    Purity: >99.00%

    An internal standard for the quantification of oxaliplatin

  • GC49275 structure
    GC492758-Oxycoptisine
    CAS: 19716-61-1
    Purity: >98.00%

    8-Oxycoptisine is a natural protoberberine alkaloid with anti-cancer activity.

  • GC49308 structure
    GC49308Ungeremine
    CAS: 2121-12-2
    Purity: >98.00%

    A betaine-type alkaloid with diverse biological activities

  • GC49670 structure
    GC49670Indium (III) thiosemicarbazone 5b
    CAS: 2345755-20-4
    Purity: >95.00%

    An anticancer agent

  • GC52104 structure
    GC52104Ponatinib (hydrochloride)
    CAS: 1114544-31-8
    Purity: >98.00%

    Ponatinib (hydrochloride) is a multi-target tyrosine kinase inhibitor that inhibits the activity of Abl (IC₅₀=0.37nM), PDGFRα (IC₅₀=1.1nM), VEGFR2 (IC₅₀=1.5nM), FGFR1 (IC₅₀=2.2nM), and Src (IC₅₀=5.4nM).

  • GC52455 structure
    GC52455Pixantrone-d8 (maleate)
    Purity: >99.00%

    An internal standard for the quantification of pixantrone

  • GC90543 structure
  • GC90660 structure
    GC90660Fz25
    CAS: 2762498-70-2
    Purity: >98.00%

    A triazole-modified sterol and an anticancer agent

  • GC91057 structure
    GC91057HP661
    Purity: >98.00%

    A mitochondrial complex I inhibitor

  • GC91096 structure
    GC91096S-72
    CAS: 2446799-14-8
    Purity: >98.00%

    An inhibitor of microtubule polymerization

  • GC91135 structure
    GC911354-(3,4-Difluorobenzo)curcumin
    CAS: 1170354-22-9
    Purity: >95.00%

    A semisynthetic coumarin with antiparasitic and anticancer activities

  • GC91152 structure
    GC91152Flavokawain 1i
    CAS: 1098176-51-2
    Purity: >98.00%

    A flavokawain derivative with anticancer and antiviral activities

  • GC91154 structure
    GC9115433-BCRP Inhibitor
    Purity: >98.00%

    A BCRP inhibitor

  • GC91403 structure
    GC91403HR68
    CAS: 2454582-64-8
    Purity: >98.00%

    HR68 is an anticancer agent and a derivative of the peroxisome proliferator-activated receptor (PPAR) agonist fenofibric acid .

  • GC91435 structure
    GC91435YCH1899
    Purity: >98.00%

    YCH1899 is an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1) and PARP2 (IC50s = 1 It is selective for PARP1 and PARP2 over PARP3, -4, -5A, -5B, -6, -7, -10, and -12 (IC50s = 1-14.1 nM).